The Unique Struggles of Being Both an Oncology Pharmacist, Caregiver for a Loved One With Cancer
April 15th 2022Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the unique struggles that come from being an oncology pharmacist and a caregiver.
Expert Discusses Role of the Pharmacist in Care Team for Targeted Therapies At AMCP Annual Meeting
April 11th 2022In an interview with Pharmacy Times®, Ryan Haumschild, PharmD, MS, MBA director of pharmacy at Emory Healthcare and Winship Cancer Institute, discusses the pharmacists role in care teams for targeted therapies at the Academy of Managed Care Pharmacy Annual Meeting.
How Oncology Pharmacists Can Provide Support, Address Barriers to Care for Patients With Cancer
April 8th 2022Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the barriers patients with cancer may experience that oncology pharmacists can help them navigate through.
Overview of New Drugs in Non-small Cell Lung Cancer, Implications for the Treatment Landscape
April 7th 2022Melissa Johnson, MD, program director of Lung Cancer Research at the Sarah Cannon Research Institute, discusses her presentation at the Community Oncology Alliance 2022 conference on new drugs in the non-small cell lung cancer space.
Expert Discusses Formulary Changes in Oncology Biosimilars at AMCP Annual Meeting
April 7th 2022In an interview with Pharmacy Times®, Eric Tichy, PharmD, MBA, BCPS, FAST, FCCP, Vice Chair of Pharmacy/Formulary at Mayo Clinic, discusses some formulary trends in biosimilars at the Academy of Managed Care Pharmacy Annual Meeting.
Despite Clinician Hesitancy, Data Support Use of Rivaroxaban in Patients with PAD, CKD
April 3rd 2022Mark Svet, MD, is the lead study author on a sub-analysis of the VOYAGER PAD study evaluating data on the use of rivaroxaban in patients with peripheral artery disease (PAD) and chronic kidney disease (CKD).
Pharmacists Can Help Manage Disparities in Health Care Access
April 2nd 2022Pharmacy Times spoke with Orly Vardeny, PharmD, MS, a core investigator at the Center for Care Delivery and Outcomes Research in the US Department of Veterans Affairs, about pharmacists’ roles in managing pharmacotherapy disparities.
The Complicated Role of Oncology Pharmacist/Caregiver in Managing Patient Care, Treatment
April 1st 2022Sarah Wheeler, PharmD, BCOP, clinical pharmacy specialist in Hematology/Oncology at UF Health Shands Cancer Hospital, discusses some of the barriers that patients with cancer may encounter following their diagnosis.
Pharmacy Students Tackle Clinical Questions in Round 2 of Pharmacy Times® Pharmacy Face-Off Gameshow
April 1st 2022In part 2 of the Pharmacy Times® Pharmacy Face-Off Gameshow™, pharmacy students from the University of the Sciences Philadelphia College of Pharmacy and the Rutgers University Ernest Mario School of Pharmacy entered a lightning round with clinical questions.
Current Guidelines, Appropriate Monitoring Recommendations for Therapies Used in Adult Sarcomas
March 31st 2022Christy S. Harris, PharmD, BCOP, FHOPA, clinical pharmacy specialist at Dana-Farber Cancer Institute, discusses guidelines for common therapies and appropriate monitoring recommendations for selected therapies used in the treatment of adult sarcomas.
Expert: USP Medicine Supply Map Can Help Pharmacists Assess the Risk in Their Medicine Supply Chains
March 31st 2022Vimala Raghavendran, MBA, head of the Pharmaceutical Supply Chain Center at US Pharmacopeia (USP), explains how pharmacists can get involved in USP’s Medicine Supply Vulnerability Insights Series assessing global pharmaceutical supply chain vulnerabilities.